Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-16-028982
Filing Date
2016-08-24
Accepted
2016-08-24 16:13:51
Documents
1
Period of Report
2016-08-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 7009
  Complete submission text file 0001179110-16-028982.txt   8381
Mailing Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142
Business Address 300 THIRD STREET FIRST FLOOR CAMBRIDGE MA 02142 617-401-9000
Editas Medicine, Inc. (Issuer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 THIRD STREET, FIRST FLOOR CAMBRIDGE MA 02142
Business Address
Glucksmann Alexandra (Reporting) CIK: 0001658390 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37687 | Film No.: 161849464